AUTHOR=Basit Syed Abdullah , Qureshi Rizwan , Musleh Saleh , Guler Reto , Rahman M. Sohel , Biswas Kabir H. , Alam Tanvir 

TITLE=COVID-19Base v3: Update of the knowledgebase for drugs and biomedical entities linked to COVID-19

JOURNAL=Frontiers in Public Health

VOLUME=11

YEAR=2023

URL=https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2023.1125917

DOI=10.3389/fpubh.2023.1125917

ISSN=2296-2565

ABSTRACT=<p>COVID-19 has taken a huge toll on our lives over the last 3 years. Global initiatives put forward by all stakeholders are still in place to combat this pandemic and help us learn lessons for future ones. While the vaccine rollout was not able to curb the spread of the disease for all strains, the research community is still trying to develop effective therapeutics for COVID-19. Although Paxlovid and remdesivir have been approved by the FDA against COVID-19, they are not free of side effects. Therefore, the search for a therapeutic solution with high efficacy continues in the research community. To support this effort, in this latest version (v3) of COVID-19Base, we have summarized the biomedical entities linked to COVID-19 that have been highlighted in the scientific literature after the vaccine rollout. Eight different topic-specific dictionaries, i.e., gene, miRNA, lncRNA, PDB entries, disease, alternative medicines registered under clinical trials, drugs, and the side effects of drugs, were used to build this knowledgebase. We have introduced a BLSTM-based deep-learning model to predict the drug-disease associations that outperforms the existing model for the same purpose proposed in the earlier version of COVID-19Base. For the very first time, we have incorporated disease-gene, disease-miRNA, disease-lncRNA, and drug-PDB associations covering the largest number of biomedical entities related to COVID-19. We have provided examples of and insights into different biomedical entities covered in COVID-19Base to support the research community by incorporating all of these entities under a single platform to provide evidence-based support from the literature. COVID-19Base v3 can be accessed from: <ext-link ext-link-type="uri" xlink:href="https://covidbase-v3.vercel.app/" xmlns:xlink="http://www.w3.org/1999/xlink">https://covidbase-v3.vercel.app/</ext-link>. The GitHub repository for the source code and data dictionaries is available to the community from: <ext-link ext-link-type="uri" xlink:href="https://github.com/91Abdullah/covidbasev3.0" xmlns:xlink="http://www.w3.org/1999/xlink">https://github.com/91Abdullah/covidbasev3.0</ext-link>.</p>